Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P1245: PARALLEL TESTING OF LIQ...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA

P1245: PARALLEL TESTING OF LIQUID BIOPSY (CTDNA) AND TISSUE BIOPSY SAMPLES REVEALS A HIGHER FREQUENCY OF TARGETABLE EZH2 MUTATIONS IN FOLLICULAR LYMPHOMA

Bibliographic Details
Main Authors: Bence Bátai, Ákos Nagy, Laura Kiss, Stefánia Gróf, Péter Attila Király, Ádám Jóna, Judit Demeter, Hermina Santa, Arpad Batai, Piroska Pettendi, Tamás Szendrei, Márk Béla Plander, Gábor Kőrösmezey, Hussain Alizadeh, Béla Kajtár, Gábor Méhes, László Krenács, Botond Timár, Judit Csomor, Erika Tóth, Tamás Schneider, Gabor Mikala, András Matolcsy, Donat Alpar, András Masszi, Csaba Bödör
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000971872.30328.9c
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000971872.30328.9c

Similar Items

  • PB1909: LOW-BURDEN TP53 MUTATIONS REPRESENT FREQUENT GENETIC EVENTS IN CLL WITH AN INCREASED RISK FOR TREATMENT INITIATION
    by: Tamás László, et al.
    Published: (2023-08-01)
  • Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation
    by: Tamás László, et al.
    Published: (2024-01-01)
  • Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia
    by: Gadó Klára, et al.
    Published: (2012-07-01)
  • Connexin 43 Communication Channels in Follicular Dendritic Cell Development and in Follicular Lymphomas
    by: Hajnalka Rajnai, et al.
    Published: (2015-01-01)
  • Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes
    by: Márk Plander, et al.
    Published: (2024-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs